中文产业新闻评分66Chinese source
智翔金泰BCMA×CD3双抗维可妥获NMPA附条件批准，系国产首个该类双抗
国产首个！智翔金泰自主研发BCMA×CD3双抗获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
国产首个！智翔金泰自主研发BCMA×CD3双抗获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.